Skip to main content
. 2024 Mar 29;12(4):761. doi: 10.3390/biomedicines12040761
ALI Acute lung injury
AMs Alveolar macrophages
AP-1 Activator protein-1
ARDS Acute respiratory distress syndrome
ATII Alveolar cell type II
BAL Bronchoalveolar lavage
cAMP Cyclic adenosine monophosphate
CAP Community-acquired pneumonia
cGMP Cyclic guanosine monophosphate
CREB cAMP response element-binding protein
CRP C-reactive protein
DAMPs Damage-associated molecular pattern molecules
ERK Extracellular signal-regulated kinases
FQs Fluoroquinolones
GM-CSF Granulocyte–macrophage colony-stimulating factor
hPBL Human peripheral blood lymphocytes
IFN Interferon
IL Interleukin
iNOS Inducible NO synthase
IκB Inhibitory κappa B
JNK c-Jun N-terminal kinases
KC Keratinocytes-derived chemokine
LPS Lipopolysaccharide
MAMPs Microbe-associated molecular patterns
MAPK Mitogen-activated protein kinase
MCP-1 Monocyte chemotactic protein
MIP-1α Macrophage inflammatory protein 1α
Mpro Main protease
NET Neutrophil extracellular trap
NF-κB Nuclear factor κappa-B
NO Nitric oxide
PAMPs Pathogen-associated molecular patterns
PBMCs Peripheral blood mononuclear cells
PDEs Phosphodiesterases
PKA Protein kinase A
PRRs Pattern recognition receptors
RBCs Red blood cells
RCT Randomised controlled trial
ROS Reactive oxygen species
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
TAK1 Transforming growth factor-activated kinase 1
TLR Toll-like receptor
TNF Tumour necrosis factor